EPRX

Eupraxia Pharmaceuticals
EPRX

Upgrade to unlock
Buy
Hold
Sell

2 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$15.5
118% upside
High target

2 analyst ratings

positive
0  neutral
0%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
Cantor Fitzgerald
Cantor Fitzgerald
Kristen Kluska
50% 1-yr EPRX win rate
15 Jan ‘26 2 months ago
HC Wainwright & Co
HC Wainwright & Co
Brandon Folkes
67% 1-yr EPRX win rate
9 Jan ‘26 2 months ago